数字经济时代，在算力浪潮之中，数据中心之于数据，犹如犀舟之于货物，起到承载、传输、存储等作用，为算力保驾护航。我们在本篇报告中重点分析了行业演变规律、美国发展经验以及上下游面临的痛点，聚焦行业未来发展趋势，我们认为头部集中化、区位分层化、运维专业化、服务智能化、技术融合化将IDC行业逐渐从无序扩张带入差异化竞争的下半场。建议关注在行业高速扩张中，提供更高服务价值、具备优质区位资源、专注技术降本增效的头部第三方IDC 公司。

Immunotherapy has emerged as an innovative treatment option over decades, as it harnesses the patient’s immune system to attack cancer. In 1891, William B. Coley, MD, first attempted to harness the immune system for treating cancer. The scientific community has been pursuing research for the development of CAR T-cell therapy over a century. The engineered CAR T-cell receptors were first created and developed in 1987 by Dr. Zelig Eshhar, an Israeli immunologist from the Weizmann Institute of Science, Israel. On August 30, 2017, Kymriah (Tisagenlecleucel), a synthetic bio immune product of anti-CD19 chimeric antigen receptor (CAR) T-cells, was approved by the U.S. FDA for the treatment of cancers such as relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL). Novarts AG is the first company to get approval for the first CAR T-cell immunotherapy. Currently, CAR T-cell therapy is developed by more than 100 companies across the globe.

Bioinformatics is used in various fields of biology. It is a combination of information technology, statistics, molecular biology, and algorithms used to analyze data obtained from various experiments. The bioinformatics market analyzed in this report includes sectors, technology & services, and applications as major segments. The technology & services segment is further classified into knowledge management tools, bioinformatics platforms, and bioinformatics services. The report analyzes the major sector markets into medical bioinformatics, agriculture, animal, academics, and others. The application segment includes proteomics, genomics, metabolomics, transcriptomics, molecular phylogenetics, and chemoinformatics. This report excludes in depth analysis of next generation sequencing and cloud-based services of bioinformatics service providers. The scope of the bioinformatics market report is to study need of integration of data in the field of bioinformatics and role played by bioinformatics tools in discovery and development of drugs and adoption level of bioinformatics tools in the developed and developing regions.

The skin forms the outer covering of the body, consisting of two specialized layers, i.e., the dermis and the epidermis. It is the largest organ of the integumentary system and performs a wide range of functions such as protecting from microbes and other foreign elements, regulating body temperature, and permitting the sensations of touch, heat, and cold. Skin substitutes are alternatives to replace the functions of the skin that can provide temporary or permanent coverage to open skin wounds. Also called dermal substitutes, skin alternatives encompass an array of biological products, including biological skin substitutes (allograft and xenograft), amniotic and placenta tissues, synthetic skin, and bioengineered skin substitutes. They are a heterogeneous group of biologic, synthetic, or biosynthetic materials that mainly aim to replicate the properties of the normal skin.

Biodegradable engine oils, also known as bio-lubricants and bio-lubes, are biodegradable and nontoxic lubricants. Organic lubricants are usually made by using raw materials such as rapeseed oil, sunflower oil, palm oil, coconut oil, and animal fats. In terms of non-toxicity, sustainability, carbon neutral, and environmentally safe, bio-lubricants provide many advantages over conventionally used petroleum-based product offerings. Attributed to the high flash point and high stability, the use of bio-lubricants over traditional lubricants is comparatively better. Bio-lubricants are used for a variety of applications across a diverse set of industries, including automotive, marine, construction, and others.

A biobank is a facility that is involved in the collection, preservation, processing, storage, and supply of biological biospecimens and associated data, which follows standardized operating procedures and provides biospecimen for scientific and clinical use. For the purpose of analysis, the global biobank market is segmented into specimen type, type of biobank, ownership, application, and region. The market study provides the dynamics and trends of the global biobanking market. It offers market estimations and forecasts for the biobanking services such as collection, preservation, processing, storage, and distribution. However, it excludes the revenue generated from the equipment, consumables, and software used in biobanks. Furthermore, excluded revenue generated from environmental repositories services.

The scope of the report is limited to revenue generated from the sales of the products used during 3D cell culturing techniques such as, spheroids, cell culture scaffolds, bioreactors, and 3D cell culture services. These products include bioreactors, hydrogels, multi-well plates, scaffolds, and microchips. The revenue generated from the 3D cell culture services include custom services on 3D cell culture products such as, microchip model developments for use in various applications. The drivers, restraints, and opportunities in the market are provided to understand the market dynamics. The market players have adopted to facilitate effective planning and decision-making.

鸿海（富士康）和浙江吉利控股组成了合资公司，双方各持股50％，该合资公司为汽车制造商和出行服务提供商提供代工生产服务。在2020 年10 月首度举办的鸿海科技日中，鸿海展示了其整合电动车硬件和软件技术的能力。鸿海的MIH 电动车平台将降低对客户和合作伙伴开发电动车的技术和资本要求。鸿海可能会成为颠覆汽车制造业的公司，因为其软件和硬件技术（内部和外部）的整合有望使其加快渗透到电动车和智能出行市场。鸿海在香港和A 股上市的子公司，包括富智康[2038.HK]、鸿腾科技[6088.HK]和工业富联[601138.CH]，可以通过提供组件和模组来参与电动车市场的发展。

Luminar是全球第一大市值激光雷达生产商。2020年12月3日，固态MEMS激光雷达生产商Luminar在纳斯达克以SPAC方式上市，是继Velodyne后全球第二家激光雷达生产商上市企业。截至2021年1月10日，公司市值达107亿美元，远高于竞争对手Velodyne 40亿美元的市值。